Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Technology
1.1.2. Treatment
1.1.3. Application
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.2. Approach 1: Commodity flow approach
1.6.3. Volume price analysis (Model 2)
1.6.4. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Technology outlook
2.2.2. Treatment outlook
2.2.3. Application outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Sacroiliac Joint Fusion Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing prevalence of lower back, buttock, groin, and lower extremity pain
3.2.1.2. Technological advancements
3.2.1.3. Growing cases of Sacroiliitis or Sacroiliac joint dysfunction
3.2.2. Market restraint analysis
3.2.2.1. Lack of awareness
3.3. Sacroiliac Joint Fusion Market Analysis Tools
3.3.1. Industry Analysis – Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. Sacroiliac Joint Fusion Market: Indication Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Degenerative sacroiliitis
4.1.2. Sacral disruption
4.1.3. Trauma
4.2. Indication Market Share, 2023 & 2030
4.3. Segment Dashboard
4.4. Global Sacroiliac Joint Fusion Market by Indication Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5.1. Degenerative sacroiliitis
4.5.1.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.5.2. Sacral disruption
4.5.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.5.3. Trauma
4.5.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. Sacroiliac Joint Fusion Market: Treatment Type Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Surgery
5.1.2. Injections
5.1.3. RF ablation
5.2. Treatment Type Market Share, 2023 & 2030
5.3. Segment Dashboard
5.4. Global Sacroiliac Joint Fusion Market by Treatment Type Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5.1. Surgery
5.5.1.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.5.2. Injections
5.5.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.5.3. RF ablation
5.5.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. Sacroiliac Joint Fusion Market: End User Estimates & Trend Analysis
6.1. Definitions and Scope
6.1.1. Hospitals
6.1.2. Ambulatory Surgical Centers
6.1.3. Others
6.2. End user Market Share, 2023 & 2030
6.3. Segment Dashboard
6.4. Global Sacroiliac Joint Fusion Market by End User Outlook
6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5.1. Hospitals
6.5.1.1. Market estimates and forecast 2018 to 2030 (USD million)
6.5.2. Ambulatory surgical centers
6.5.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.5.3. Others
6.5.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 7. Sacroiliac Joint Fusion Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2023 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.5. North America
7.5.1. U.S.
7.5.1.1. U.S. market estimates and forecast, 2018 – 2030 (USD Million)
7.5.2. Canada
7.5.2.1. Canada market estimates and forecast, 2018 – 2030 (USD Million)
7.6. Europe
7.6.1. UK
7.6.1.1. UK market estimates and forecast, 2018 – 2030 (USD Million)
7.6.2. Germany
7.6.2.1. Germany market estimates and forecast, 2018 – 2030 (USD Million)
7.6.3. France
7.6.3.1. France market estimates and forecast, 2018 – 2030 (USD Million)
7.6.4. Italy
7.6.4.1. Italy market estimates and forecast, 2018 – 2030 (USD Million)
7.6.5. Spain
7.6.5.1. Spain market estimates and forecast, 2018 – 2030 (USD Million)
7.6.6. Norway
7.6.6.1. Norway market estimates and forecast, 2018 – 2030 (USD Million)
7.6.7. Sweden
7.6.7.1. Sweden market estimates and forecast, 2018 – 2030 (USD Million)
7.6.8. Denmark
7.6.8.1. Denmark market estimates and forecast, 2018 – 2030 (USD Million)
7.7. Asia Pacific
7.7.1. Japan
7.7.1.1. Japan market estimates and forecast, 2018 – 2030 (USD Million)
7.7.2. China
7.7.2.1. China market estimates and forecast, 2018 – 2030 (USD Million)
7.7.3. India
7.7.3.1. India market estimates and forecast, 2018 – 2030 (USD Million)
7.7.4. Australia
7.7.4.1. Australia market estimates and forecast, 2018 – 2030 (USD Million)
7.7.5. South Korea
7.7.5.1. South Korea market estimates and forecast, 2018 – 2030 (USD Million)
7.7.6. Thailand
7.7.6.1. Thailand market estimates and forecast, 2018 – 2030 (USD Million)
7.8. Latin America
7.8.1. Brazil
7.8.1.1. Brazil market estimates and forecast, 2018 – 2030 (USD Million)
7.8.2. Mexico
7.8.2.1. Mexico market estimates and forecast, 2018 – 2030 (USD Million)
7.8.3. Argentina
7.8.3.1. Argentina market estimates and forecast, 2018 – 2030 (USD Million)
7.9. MEA
7.9.1. South Africa
7.9.1.1. South Africa market estimates and forecast, 2018 – 2030 (USD Million)
7.9.2. Saudi Arabia
7.9.2.1. Saudi Arabia market estimates and forecast, 2018 – 2030 (USD Million)
7.9.3. UAE
7.9.3.1. UAE market estimates and forecast, 2018 – 2030 (USD Million)
7.9.4. Kuwait
7.9.4.1. Kuwait market estimates and forecast, 2018 – 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.2.1. Innovators
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2023
8.3.4. SI-BONE, Inc.
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. PainTEQ
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. CornerLoc
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. SIGNUS Medizintechnik GmbH
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Globus Medical
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Product benchmarking
8.3.8.4. Strategic initiatives
8.3.9. Orthofix Medical, Inc.
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives
8.3.10. Life Spine, Inc.
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Product benchmarking
8.3.10.4. Strategic initiatives
8.3.11. Camber Spine Technologies, LLC
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Product benchmarking
8.3.11.4. Strategic initiatives
8.3.12. CoreLink Surgical
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Product benchmarking
8.3.12.4. Strategic initiatives
8.3.13. Xtant Medical
8.3.13.1. Company overview
8.3.13.2. Financial performance
8.3.13.3. Product benchmarking
8.3.13.4. Strategic initiatives
8.3.14. Surgalign Spine Technologies, Inc.
8.3.14.1. Company overview
8.3.14.2. Financial performance
8.3.14.3. Product benchmarking
8.3.14.4. Strategic initiatives
8.3.15. Medtronic
8.3.15.1. Company overview
8.3.15.2. Financial performance
8.3.15.3. Product benchmarking
8.3.15.4. Strategic initiatives
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/